CD8A and mesothelioma: EVs produced by various cancer cell lines in vitro or isolated from pleural effusions from patients with mesothelioma carry natural killer group 2 (NKG2D) ligands that downregulate the surface expression of NKG2D in NK and CD8+ T cells, which prevent NK and CD8+ T cell activation.45